Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00445406
Status:
COMPLETED
Last Update Posted:
2012-06-28
First Post:
2007-03-07
Brief Title:
Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Sponsor:
Swiss Group for Clinical Cancer Research
Organization:
Swiss Group for Clinical Cancer Research
Organization Data
Organization:
Swiss Group for Clinical Cancer Research
Class:
OTHER
Study ID:
SAKK 2406
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Swiss Group for Clinical Cancer Research
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None